Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose d-cycloserine augmentation of CBT for panic disorder
2012-003191-39Phase 4Terminated
- Sponsor
- University of Oxford
- Start
- Dec 2012
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in panic disorder comparing d-cycloserine + CBT with Placebo + CBT (2 arms). Primary endpoint: Threat bias reaction time scores. Started Dec 2012; status: terminated.
02
Drugs
d-cycloserine
03
Conditions
panic disorder
Beyond the preview
Go deeper on 2012-003191-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003191-39.